- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04318990
DIstal vs Proximal Radial Artery Access for Cath (DIPRA)
November 16, 2023 updated by: Baylor Research Institute
Distal vs. Proximal Radial Artery Access for Cardiac Catheterization and Intervention
This single-center, prospective, randomized study will evaluate distal radial artery (dRA) vs. proximal radial artery access (pRA) in regards to hand function and radial artery occlusion.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Primary objective is to evaluate hand function following distal radial artery access compared to proximal artery access in patients undergoing cardiac catheterization.
Hand function will be assessed by:
- QuickDASH questionnaire
- Hand grip test
- Thumb forefinger pinch test utilizing a pinch gauge
Secondary objectives: Vascular access success rates, hematoma, bleeding, complications of vascular access and radial artery occlusion.
Study Type
Interventional
Enrollment (Actual)
300
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Plano, Texas, United States, 75093
- Baylor Scott & White The Heart Hospital - Plano
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥ 18 years.
- The distal and proximal radial artery must be palpable and non-occlusive flow must be confirmed by (Doppler) ultrasound.
- Patient should be able to comply with the protocol.
- Provide written informed consent before study participation
Exclusion Criteria:
- Obligatory femoral or forearm radial access
- Previous ipsilateral forearm radial artery occlusion.
- Patient on therapeutic oral anticoagulation.
- Very large hand/wrist anatomy that will preclude using the available hemostatic radial bands.
- Enrolment in another study that competes or interferes with this study.
- Poor clinical condition like cardiogenic shock, which prohibits pre- and post-procedural function tests.
- Subject with planned complex PCI or procedure necessitating multiple intervention.
- Any other condition or co-morbidity which, in the opinion of the investigator or operator, may pose a significant hazard to the subject if he or she is enrolled in the study.
- History of stroke with residual deficit that affects hand function.
- Previous radial artery catheterization within 1 year.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Distal radial artery access
Wrist rests on a comfortable underground which brings the wrist in passive ulnar flexion.
Patient is asked to bring the thumb under the other four fingers.
After disinfection, patient is covered with a sterile drape.
Brachial drape is applied to the hand exposing the anatomical snuff box and the proximal radial.
Under ultrasound guidance, local anesthesia applied by SC injection of 5cc of lidocaine filling the radial fossa.
Puncture performed at the point of maximal pulsation proximal in the anatomical snuffbox.
If fails, a puncture more distal, can be attempted.
After successful anterior wall puncture a radial sheath wire is advanced.
Proper position verified by fluoroscopy or by ultrasound to ensure the wire didn't traverse the palmar arch, followed by introduction of a hydrophilic sheath.
After administration of a spasmolytic cocktail containing 200-400 mcg of nitroglycerin and 5 mg of verapamil, the operator can take up a position at the level of the patient's knees.
|
Patients undergoing coronary angiography or angioplasty at The Heart Hospital Baylor Plano will be randomized 1:1 to distal or proximal radial access for cardiac catheterization.
|
|
Active Comparator: Proximal radial artery access
Half of the patients enrolled in the study undergoing coronary angiography or angioplasty at The Heart Hospital Baylor Plano will be randomized proximal radial access for cardiac catheterization.
|
Patients undergoing coronary angiography or angioplasty at The Heart Hospital Baylor Plano will be randomized 1:1 to distal or proximal radial access for cardiac catheterization.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quick Disabilities of the Arm Shoulder and Hand (DASH) Questionnaire Score (0-100)
Time Frame: 1 year
|
Hand function questionnaire, Range: 0 (no disability) to 100 (most severe disability)
|
1 year
|
|
Thumb and Forefinger Pinch Strength Test
Time Frame: 1 year
|
Hand function: Thumb and forefinger pinch strength (kg)
|
1 year
|
|
Hand Grip Strength Test
Time Frame: 1 month
|
Hand grip strength test (kg)
|
1 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Re-intervention Using the Radial Artery
Time Frame: 1 year
|
Patients who required re-intervention using the radial artery up to 1 year following the initial intervention
|
1 year
|
|
Radial Artery Occlusion
Time Frame: 1 year
|
Occurrence of distal radial artery occlusion and proximal radial artery occlusion for patients who had distal or proximal radial artery access
|
1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 6, 2020
Primary Completion (Actual)
December 31, 2021
Study Completion (Actual)
December 31, 2022
Study Registration Dates
First Submitted
March 19, 2020
First Submitted That Met QC Criteria
March 20, 2020
First Posted (Actual)
March 24, 2020
Study Record Updates
Last Update Posted (Actual)
May 3, 2024
Last Update Submitted That Met QC Criteria
November 16, 2023
Last Verified
March 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 019-504 DIPRA
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.